Literature DB >> 28526992

Epithelial Mesenchymal Transition (EMT) in Metastatic Breast Cancer in Omani Women.

Ritu Lakhtakia1, Adil Aljarrah2, Muhammad Furrukh3, Shyam S Ganguly4.   

Abstract

Breast cancer (BC) in Oman affects younger women and has a more aggressive course. Clinical and biological variables like age, pregnancy, tumor size, type, grade, receptor expression and proliferation predict disease aggression but there is no direct predictor of metastasis except lymphovascular invasion. Epithelial-mesenchymal transition (EMT) is characterized by epithelial cells losing epithelial and acquiring mesenchymal morpho-immunophenotypic characteristics. In tumors, EMT-like transitions may signify a metastatic phenotype and have features in common with cancer stem cells (CSC) which show resistance to chemotherapy. This study aimed to identify EMT and CSC phenotypes in metastatic and non-metastatic breast cancer in Omani women and their association with conventional clinico-pathological predictors of BC. In a retrospective study of ninety-six Omani women with breast cancer, the association of age, pregnancy/lactation, tumor size, type, grade, ductal carcinoma insitu (DCIS), lymphovascular invasion, hormone/ HER2 receptor expression and Ki67 proliferation index (Ki67 PI) was tested with EMT/ CSC phenotype and metastasis. Young age ≤ 40 years, lymphovascular invasion and EMT had a strong association with metastasis; CSC approached significance. Vimentin expression in tumor cells, fibronectin and MMP-11 in stroma were reliable markers of EMT; dual EMT and CSC phenotype (Vim+/ CD44+/ CD 24-/low) had a strong association with apocrine variant, basal-like tumors and triple negative cancers. EMT had a strong association with Ki67 proliferation index (PI) and CSC with HER2-like tumors and distant metastasis. These select markers may be useful in metastasis-prediction in pre-treatment biopsies.

Entities:  

Keywords:  Breast cancer (BC); Cancer stem cell (CSC); Epithelial mesenchymal transition (EMT); Metastasis; Pregnancy-associated breat cancer (PABC); Young women with breast cancer

Year:  2017        PMID: 28526992      PMCID: PMC5750198          DOI: 10.1007/s12307-017-0194-9

Source DB:  PubMed          Journal:  Cancer Microenviron        ISSN: 1875-2284


  68 in total

1.  AACR special conference on epithelial-mesenchymal transition and cancer progression and treatment.

Authors:  Evanthia T Roussos; Zuzana Keckesova; John D Haley; David M Epstein; Robert A Weinberg; John S Condeelis
Journal:  Cancer Res       Date:  2010-09-07       Impact factor: 12.701

Review 2.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

Authors:  Jing Yang; Robert A Weinberg
Journal:  Dev Cell       Date:  2008-06       Impact factor: 12.270

Review 3.  The distribution of fibronectin, laminin and tetranectin in human breast cancer with special attention to the extracellular matrix.

Authors:  L Christensen
Journal:  APMIS Suppl       Date:  1992

4.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

Review 5.  Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Authors:  Thomas Brabletz; Andreas Jung; Simone Spaderna; Falk Hlubek; Thomas Kirchner
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

Review 6.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

7.  Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma.

Authors:  Richard C Bates; David I Bellovin; Courtney Brown; Elizabeth Maynard; Bingyan Wu; Hisaaki Kawakatsu; Dean Sheppard; Peter Oettgen; Arthur M Mercurio
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

8.  Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis.

Authors:  Benny K Abraham; Peter Fritz; Monika McClellan; Petra Hauptvogel; Maria Athelogou; Hiltrud Brauch
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

9.  Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.

Authors:  Jason I Herschkowitz; Karl Simin; Victor J Weigman; Igor Mikaelian; Jerry Usary; Zhiyuan Hu; Karen E Rasmussen; Laundette P Jones; Shahin Assefnia; Subhashini Chandrasekharan; Michael G Backlund; Yuzhi Yin; Andrey I Khramtsov; Roy Bastein; John Quackenbush; Robert I Glazer; Powel H Brown; Jeffrey E Green; Levy Kopelovich; Priscilla A Furth; Juan P Palazzo; Olufunmilayo I Olopade; Philip S Bernard; Gary A Churchill; Terry Van Dyke; Charles M Perou
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

10.  Classification of circulating tumor cells by epithelial-mesenchymal transition markers.

Authors:  Shiyang Wu; Suyan Liu; Zhiming Liu; Jiefeng Huang; Xiaoyu Pu; Jing Li; Dinghua Yang; Haijun Deng; Ning Yang; Jiasen Xu
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

View more
  5 in total

1.  Immunohistochemical Expression of Vimentin in Invasive Breast Carcinoma and Its Correlation with Clinicopathological Parameters.

Authors:  Chaitnya D Khillare; Siddhi Gaurish Sinai Khandeparkar; Avinash R Joshi; Maithili M Kulkarni; Bageshri P Gogate; Shivani Battin
Journal:  Niger Med J       Date:  2019 Jan-Feb

2.  Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer.

Authors:  Marketa Koleckova; Jiri Ehrmann; Jan Bouchal; Maria Janikova; Aneta Brisudova; Josef Srovnal; Katerina Staffova; Marek Svoboda; Ondrej Slaby; Lenka Radova; Katherine Vomackova; Bohuslav Melichar; Lucia Veverkova; Zdenek Kolar
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

3.  Effect of miR-25 on Proliferation of Nasopharyngeal Carcinoma Cells through Wnt/β-Catenin Signaling Pathway.

Authors:  Haixia He; Kun Yuan; Wei Chen
Journal:  Biomed Res Int       Date:  2021-08-26       Impact factor: 3.411

4.  The Difference of Expression of 18 Genes in Axillary Invasion and Vascular Invasion Compared to Control Samples in Breast Cancer.

Authors:  Alireza Abdollahi; Sepideh Jahanian; Nima Hemmati; Hadis Mohammadpour
Journal:  Iran J Pathol       Date:  2019-08-01

5.  N2E4, a Monoclonal Antibody Targeting Neuropilin-2, Inhibits Tumor Growth and Metastasis in Pancreatic Ductal Adenocarcinoma via Suppressing FAK/Erk/HIF-1α Signaling.

Authors:  Li Wang; Lanlan Wang; Shengyu Wang; Zonglang Zhou; Zongjunlin Liu; Peilan Xu; Xian Luo; Ting Wu; Fanghong Luo; Jianghua Yan
Journal:  Front Oncol       Date:  2021-07-15       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.